Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

PURPOSE: The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data that test this paradigm are lacking. METHODS: We enrolled patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Palma, David A., Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V., Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B., Yaremko, Brian P., Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S., Laba, Joanna, Qu, X. Melody, Warner, Andrew, Senan, Suresh
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2020
Témata:
RAPID COMMUNICATIONS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460150/
https://ncbi.nlm.nih.gov/pubmed/32484754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00818
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky